Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nyanza Rothman

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
JCI Insight|March 15, 2017
Eomesodermin and T-bet mark developmentally distinct human natural killer cellsAmélie Collins, Nyanza Rothman, Kang Liu, et al.
JCI Insight|September 26, 2023
Skeletal phenotype amelioration in mucopolysaccharidosis VI requires intervention at the earliest stages of postnatal developmentElizabeth Hwang-Wong, Gabrielle Amar, Nanditha Das, et al.
The Journal of Clinical Investigation|May 5, 2022
Anti-ACVR1 antibodies exacerbate heterotopic ossification in fibrodysplasia ossificans progressiva (FOP) by activating FOP-mutant ACVR1Senem Aykul, Lily Huang, Lili Wang, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
JCI Insight|March 15, 2017
Eomesodermin and T-bet mark developmentally distinct human natural killer cellsAmélie Collins, Nyanza Rothman, Kang Liu, et al.
JCI Insight|September 26, 2023
Skeletal phenotype amelioration in mucopolysaccharidosis VI requires intervention at the earliest stages of postnatal developmentElizabeth Hwang-Wong, Gabrielle Amar, Nanditha Das, et al.
The Journal of Clinical Investigation|May 5, 2022
Anti-ACVR1 antibodies exacerbate heterotopic ossification in fibrodysplasia ossificans progressiva (FOP) by activating FOP-mutant ACVR1Senem Aykul, Lily Huang, Lili Wang, et al.
Pageof 1